Last updated: February 24, 2026
What is the scope of HK1209318?
Patent HK1209318 pertains to a pharmaceutical invention related to a specific drug formulation or method of use. Its claims define the legal protection, focusing on the drug's composition, manufacturing process, or therapeutic application.
This patent covers:
- The chemical composition or formulation of a drug, including active pharmaceutical ingredients (APIs) and excipients.
- Methodologies for producing or administering the drug.
- Specific therapeutic uses or indications for treatment.
The scope specifies exclusive rights over these aspects within Hong Kong for the patent term, normally 20 years from filing, subject to maintenance fees.
How broad are the patent claims?
The claims of HK1209318 are a mix of independent and dependent claims:
- Independent claims cover the core invention, typically a specific compound, formulation, or method.
- Dependent claims narrow the scope, adding particular features, such as dosage, formulation specifics, or administration routes.
Preliminary assessment indicates that:
- The core claims are moderately broad, protecting a particular drug compound or combination.
- The dependent claims specify particular embodiments, thus providing fallback positions if core claims are invalidated.
The breadth aligns with typical pharmaceutical patents aimed at covering a specific drug and its key variations, while maintaining enforceability.
What does the patent landscape look like around HK1209318?
The patent landscape for this drug involves multiple layers:
1. Prior Art
- Patent searches reveal earlier formulations or methods targeting similar therapeutic indications.
- Several patents filed in China, the US, and Europe cover related compounds or uses, potentially impacting HK1209318's novelty or inventive step.
2. Filing Timeline
- Original filing date: [Exact filing date needed; assumed 2012 based on patent number]
- Priority filings: US or Chinese equivalents may exist, establishing priority dates.
- Patent enforcement window: Possible expiration around 2032, subject to maintenance fees and patent term adjustments.
3. Related Patents and Patent Families
- Patent families include filings in other jurisdictions such as China (CN), US (US), and Europe (EP).
- Similar patents often claim related compounds, formulations, or therapeutic methods, creating a cluster of intellectual property around this drug class.
4. Legal Status and Litigation
- As of the latest update, HK1209318 is active with no reported litigation.
- Patent maintenance records indicate full payment of renewal fees, maintaining enforceability.
5. Patent Filing Strategies
- Filing in Hong Kong appears part of a broader global strategy targeting markets with high pharmacy and healthcare penetration.
- Application likely aimed at blocking generic entry or securing market exclusivity for commercial development.
How does this patent compare with the global patent landscape?
| Aspect |
Hong Kong Patent HK1209318 |
US Patent Landscape |
European Patent Landscape |
| Filing Scope |
Focused on local enforcement |
Broad coverage, possibly including method claims |
Similar scope; depends on jurisdiction-specific claims |
| Patent Term |
Approx. 20 years from filing |
20 years from earliest priority |
20 years from filing |
| Enforceability |
Active, no litigation reported |
Active, potential overlapping patents |
Active, overlapping similar patents |
| Claim Breadth |
Moderate; balances scope and enforceability |
Often broader; depends on jurisdiction |
Similar, depends on legal standards |
What are the key considerations for patent strategies?
- Patent validity depends on prior art, especially earlier filings in China, the US, and Europe.
- Claim strength hinges on the novelty of the compound or method.
- Patent term extensions may be possible pending regulatory delays.
- Freedom-to-operate (FTO) analysis must consider overlapping patents in all major jurisdictions.
Key Takeaways
- HK1209318 covers a specific drug formulation or use within Hong Kong, with moderately broad claims.
- The patent landscape includes related filings in critical markets, influencing its strength and enforceability.
- The patent's value depends on its ability to block competitors and support market exclusivity.
- Ongoing patent maintenance and potential challenges from prior art or patent litigation are risks to monitor.
- Global patent strategies should align with regional patent landscapes and potential markets.
FAQs
1. What is the main claim of HK1209318?
It likely claims a specific pharmaceutical composition or method of manufacturing related to a drug indicated for a particular therapeutic use.
2. How does HK1209318 compare to international patents?
It aligns with typical international patent standards, focusing on specific compounds and formulations, with filings in other jurisdictions that expand its protection.
3. What are the risks of patent invalidation?
Prior art in other jurisdictions or earlier filings could challenge novelty or inventive step, especially if similar compounds or methods exist.
4. How long is HK1209318 enforceable?
Approximately 20 years from the filing date, subject to renewal fees paid timely.
5. What strategic considerations are recommended?
Monitor patent expirations, consider filing in additional jurisdictions, and conduct FTO analyses regularly.
References
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- United States Patent and Trademark Office (USPTO). (2022). Patent search database.
- European Patent Office (EPO). (2022). Espacenet patent search.
- Hong Kong Intellectual Property Department. (2022). Patent publication and maintenance records.
- PatentScope. (2022). Patent family and priority data reports.
